Cargando…
Putting epigenetic biomarkers to the test for clinical trials
Reliable biomarkers are needed to test the effectiveness of interventions intended to improve health and extend lifespan.
Autores principales: | Justice, Jamie N, Kritchevsky, Stephen B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282804/ https://www.ncbi.nlm.nih.gov/pubmed/32515735 http://dx.doi.org/10.7554/eLife.58592 |
Ejemplares similares
-
Epigenetic scores for the circulating proteome as tools for disease prediction
por: Gadd, Danni A, et al.
Publicado: (2022) -
Correction: Epigenetic scores for the circulating proteome as tools for disease prediction
por: Gadd, Danni A, et al.
Publicado: (2023) -
BIOMARKER STRATEGIES FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019) -
DunedinPACE, a DNA methylation biomarker of the pace of aging
por: Belsky, Daniel W, et al.
Publicado: (2022) -
Urinary metabolic biomarkers of diet quality in European children are associated with metabolic health
por: Stratakis, Nikos, et al.
Publicado: (2022)